glp-1 eczema GLP-1s in Dermatology Managing Pigmentation From Severe Eczema:

Not for human, veterinary, diagnostic, therapeutic or in-vivo use

This aligns with findings from SURPASS-CVOT, which showed no meaningful additive effect on MACE compared to an older GLP-1 receptor agonist, and with findings of a potential greater protection in heart failure that could be compatible with more pronounced weight loss mediated by GIP 16,22

Retrieved March 10, 2026, from 3 Nania, R., (2025, December 23)

Some patients may require more aggressive dosing while others may be quite sensitive and opt to remain at lower doses

Withdraw the needle gently and discard it in a sharps container

Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis